$200K — $250K *
At CRISPR Therapeutics, we are focused on developing transformative gene-based medicines for serious human diseases.
We are rapidly translating our specific, efficient, and versatile CRISPR/Cas9 gene-editing platform into therapies to treat hemoglobinopathies, cancer, diabetes, and other diseases.
Our multi-disciplinary team of world-class researchers and drug developers works every day to translate our CRISPR/Cas9 technology into breakthrough human therapeutics. Our lead program targeting the blood diseases β-thalassemia and sickle cell disease has entered clinical testing, and our immuno-oncology programs, focused on CRISPR/Cas9-edited allogeneic CAR-T cell therapies, have the potential to deliver a new generation of cancer therapies to patients.
The Director of Biostatistics is responsible for leading, developing and implementing statistical solutions to optimally support all phases of clinical trials and decision making. The successful candidate will function as the lead statistician across clinical development programs, and may supervise study level statistician in-house and at CROs and be accountable for all biostatistics study deliverables. The role will include key trial statistician responsibilities including statistical design of all phases of trials, authoring of SAPs, and conducting just-in-time analyses and data exploration. Industry experience is required; experience with regulatory filings strongly preferred.
Reporting to the Head of Biometrics, the successful candidate will have the opportunity to take a leadership role in the Biometrics function at CRISPR, and must possess the desire and ability to work with study teams up through and including leadership responsibilities.
CRISPR Therapeutics, Inc. is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, gender, age, religion, national origin, ancestry, disability, veteran status, genetic information, sexual orientation or any characteristic protected under applicable law.
Valid through: 2/24/2021
$200K — $250K
21 days ago